Journal article Open Access

Allopurinol pharmacogenetics: assessment of potential clinical usefulness

Zineh, Issam; Mummaneni, Padmaja; Lyndly, Jenna; Amur, Shashi; La Grenade, Lois A.; Chang, Stephen H.; Rogers, Hobart; Pacanowski, Michael A.


JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://zenodo.org/api/files/3e39f605-a56e-41a5-a5c5-6a7490c1c442/article.pdf"
      }, 
      "checksum": "md5:ab16844f6a1b920eedb078c9f3c0ef79", 
      "bucket": "3e39f605-a56e-41a5-a5c5-6a7490c1c442", 
      "key": "article.pdf", 
      "type": "pdf", 
      "size": 648813
    }
  ], 
  "owners": [
    13380
  ], 
  "doi": "10.2217/pgs.11.131", 
  "stats": {
    "version_unique_downloads": 169.0, 
    "unique_views": 246.0, 
    "views": 256.0, 
    "version_views": 256.0, 
    "unique_downloads": 169.0, 
    "version_unique_views": 246.0, 
    "volume": 114191088.0, 
    "version_downloads": 176.0, 
    "downloads": 176.0, 
    "version_volume": 114191088.0
  }, 
  "links": {
    "doi": "https://doi.org/10.2217/pgs.11.131", 
    "latest_html": "https://zenodo.org/record/1236437", 
    "bucket": "https://zenodo.org/api/files/3e39f605-a56e-41a5-a5c5-6a7490c1c442", 
    "badge": "https://zenodo.org/badge/doi/10.2217/pgs.11.131.svg", 
    "html": "https://zenodo.org/record/1236437", 
    "latest": "https://zenodo.org/api/records/1236437"
  }, 
  "created": "2018-04-28T19:31:12.533591+00:00", 
  "updated": "2020-01-20T16:24:32.202313+00:00", 
  "conceptrecid": "1236436", 
  "revision": 5, 
  "id": 1236437, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.2217/pgs.11.131", 
    "description": "Use of pharmacogenetics to inform treatment decisions remains a priority for clinicians, patients and public health agencies. We previously developed a framework for systematically assessing whether pharmacogenetic test information would likely bring value to clinical decision-making and enjoy practical uptake. We applied this tool to allopurinol to determine potential usefulness of HLA genetic information in assessing risk for allopurinol-induced severe cutaneous adverse reactions. We quantified allopurinol use data and the magnitude of adverse event signals using US FDA databases, reviewed reported cases of allopurinol-associated severe cutaneous adverse reactions to assess whether clinical subtypes of patients could be identified, performed pooled analyses of associations between HLA variation and allopurinol-induced severe cutaneous adverse reactions and described considerations in clinical implementation of allopurinol pharmacogenetics.", 
    "license": {
      "id": "CC0-1.0"
    }, 
    "title": "Allopurinol pharmacogenetics: assessment of potential clinical usefulness", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "1236436"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "1236437"
          }
        }
      ]
    }, 
    "publication_date": "2011-12-01", 
    "creators": [
      {
        "name": "Zineh, Issam"
      }, 
      {
        "name": "Mummaneni, Padmaja"
      }, 
      {
        "name": "Lyndly, Jenna"
      }, 
      {
        "name": "Amur, Shashi"
      }, 
      {
        "name": "La Grenade, Lois A."
      }, 
      {
        "name": "Chang, Stephen H."
      }, 
      {
        "name": "Rogers, Hobart"
      }, 
      {
        "name": "Pacanowski, Michael A."
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "article", 
      "type": "publication", 
      "title": "Journal article"
    }
  }
}
256
176
views
downloads
Views 256
Downloads 176
Data volume 114.2 MB
Unique views 246
Unique downloads 169

Share

Cite as